Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 501–600 of 1,001
Cellular and Molecular Biology of Orphan G Protein‐Coupled Receptors
Oh, D. Y., Kim, K., Kwon, H. B., & Seong, J. Y. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)52003-0 · Cited by 59
PPARγ and MEK Interactions in Cancer
Burgermeister, E., & Seger, R. (2008) · PPAR Research · doi:10.1155/2008/309469 · Cited by 60
Wang, L., Zhao, Y., Gui, B., Fu, R., Ma, F., Yu, J. M., Qü, P., Dong, L., & Chen, C. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0132 · Cited by 58
Soni, M. S., Rabaglia, M. E., Bhatnagar, S., Shang, J., Ilkayeva, O., Mynatt, R. L., Zhou, Y., Schadt, E. E., Thornberry, N. A., Muoio, D. M., et al. (2014) · Diabetes · doi:10.2337/db13-1677 · Cited by 54
“Fatty acids acutely regulate cellular Ca levels through activation of GPR40, leading to enhanced IS (9).”
BackgroundHolliday, N. D., Watson, S., & Brown, A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00112 · Cited by 53
“Initial investigations derived similar agonist pharmacology for human, rat, and mouse FFA1 receptors (Itoh et al., 2003).”
BackgroundMethodInfluentialMikami, S., Kitamura, S., Negoro, N., Sasaki, S., Suzuki, M., Tsujihata, Y., Miyazaki, T., Ito, R., Suzuki, N., Miyazaki, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2016123 · Cited by 53
Sona, C., Kumar, A., Dogra, S., Kumar, B. A., Umrao, D., & Yadav, P. N. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.002 · Cited by 60
Kishikawa, A., Kitaura, H., Kimura, K., Ogawa, S., Qi, J., Shen, W.-R., Ohori, F., Noguchi, T., Marahleh, A., Nara, Y., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00157 · Cited by 55
“It has been reported that free fatty acids can activate receptors GPR40 (free fatty acid receptor: FFAR1), GPR41 (FFAR3), GPR43 (FFAR2), GPR84, and GPR120 (FFAR4) and long-chain fatty acids can activate GPR40 and GPR120 (25, 26).”
BackgroundRonnebaum, S. M., Joseph, J. W., Ilkayeva, O., Burgess, S. C., Lu, D., Becker, T. C., Sherry, A. D., & Newgard, C. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800119200 · Cited by 53
Hamid, Y. H., Vissing, H., Holst, B., Urhammer, S. A., Pyke, C., Hansen, S. K., Glümer, C., Borch‐Johnsen, K., Jørgensen, T., Schwartz, T. W., et al. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01505.x · Cited by 56
Emerging roles of β-cell mitochondria in type-2-diabetes
Las, G., Oliveira, M. F., & Shirihai, O. S. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100843 · Cited by 51
A pathway model of glucose-stimulated insulin secretion in the pancreatic β-cell
Maheshvare, M. D., Raha, S., König, M., & Pal, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185656 · Cited by 63
Mechanisms and effects of “fat taste” in humans
Tucker, R. M., Mattes, R. D., & Running, C. A. (2014) · BioFactors · doi:10.1002/biof.1162 · Cited by 61
Humphries, P. S., Benbow, J. W., Bonin, P. D., Boyer, D. D., Doran, S. D., Frisbie, R. K., Piotrowski, D. W., Balan, G., Bechle, B. M., Conn, E. L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.082 · Cited by 52
Drug Design for G‐Protein‐Coupled Receptors by a Ligand‐Based NMR Method
Bartoschek, S., Klabunde, T., Defoßa, E., Dietrich, V., Stengelin, S., Griesinger, C., Carlomagno, T., Focken, I., & Wendt, K. U. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200905102 · Cited by 51
The role of G protein-coupled receptor 40 in lipoapoptosis in mouse β-cell line NIT-1
Zhang, Y., Xu, M., Zhang, S., Yan, L., Yang, C., Lu, W., Li, Y., & Cheng, H. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-06-0048 · Cited by 59
“Recent studies documented that GPR40 mediates both acute stimulatory and chronic inhibitory effects of FFAs on insulin secretion and that GPR40 signaling is linked to impaired glucose homeostasis (Itoh et al. 2003, Itoh & Hinuma 2005, Shapiro et al. 2005, Steneberg et al. 2005, Tomita et al. 2006).”
InfluentialYazaki, R., Kumagai, N., & Shibasaki, M. (2011) · Organic Letters · doi:10.1021/ol102998w · Cited by 57
Molecular imaging of β-cells: diabetes and beyond
Wei, W., Ehlerding, E. B., Lan, X., Luo, Q., & Cai, W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.022 · Cited by 51
Maissan, P., Mooij, E., & Barberis, M. (2021) · Biology · doi:10.3390/biology10030194 · Cited by 48
Nakamoto, K., Nishinaka, T., Sato, N., Aizawa, F., Yamashita, T., Mankura, M., Kōyama, Y., Kasuya, F., & Tokuyama, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13003 · Cited by 55
“…as the free fatty acid receptor 1 (FFA1 receptor) and is activated by long-chain fatty acids, such as docosahexaenoic acid (DHA), arachidonic acid and eicosapentaenoic acid and is expressed predominantly in the CNS and in β-cells in the pancreatic islets (Briscoe et al., 2003; Itoh et al., 2003).”
n-3 polyunsaturated fatty acids and insulin secretion
Wang, X., & Chan, C. B. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0581 · Cited by 55
Sargsyan, E., Artemenko, K. A., Manukyan, L., Bergquist, J., & Bergsten, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.06.012 · Cited by 56
“It has been hypothesized that oleate prevents the negative effects of palmitte by activating FFAR1 signaling [17].”
InfluentialDrzazga, A. K., Kristinsson, H., Sałaga, M., Zatorski, H., Koziołkiewicz, M., Gendaszewska‐Darmach, E., & Bergsten, P. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.12.002 · Cited by 53
Macrophages regulate lung ILC2 activation via Pla2g5-dependent mechanisms
Yamaguchi, M., Samuchiwal, S. K., Quehenberger, O., Boyce, J. A., & Balestrieri, B. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.99 · Cited by 53
Indanes—Properties, Preparation, and Presence in Ligands for G Protein Coupled Receptors
Vilums, M., Heuberger, J. A. A. C., Heitman, L. H., & IJzerman, A. P. (2015) · Medicinal Research Reviews · doi:10.1002/med.21352 · Cited by 55
Zhang, Q., Yang, H., Li, J. X., & Xie, X. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232033 · Cited by 50
“In the past 15 years, FFAs have been found to activate several G protein–coupled receptors (GPCRs), which are named free fatty acid receptors (FFARs), including G protein–coupled receptor 40 [GPR40 (FFAR1)], GPR41 (FFAR3), GPR43 (FFAR2), GPR84, GPR119, and GPR120 (FFAR4) (Brown et al., 2003; Itoh et al., 2003; Hirasaw…”
BackgroundHidalgo, J., Teuber, S., Morera, F. J., Ojeda, C., Flores, C. A., Hidalgo, M. A., Núñez, L., Villalobos, C., & Burgos, R. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040750 · Cited by 51
“Eicosapentaenoic acid (EPA), a natural FFA1 agonist [26,36], also releases Ca2+ from the endoplasmic reticulum in colonic epithelial cells, followed by the “store operated” cAMP increase [37].”
BackgroundEndogenous Fatty Acids Are Essential Signaling Factors of Pancreatic β-Cells and Insulin Secretion
Hauke, S., Keutler, K., Phapale, P. B., Yushchenko, D. A., & Schultz, C. (2018) · Diabetes · doi:10.2337/db17-1215 · Cited by 53
Metabolic Regulation of Insulin Secretion
Keane, K. N., & Newsholme, P. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800174-5.00001-6 · Cited by 61
“For instance, downregulation of GPR40 (or free fatty acid receptor-1, FFAR-1) in rat b-cells and islets, reduced FFA-amplification of GSIS (Itoh et al., 2003), while studies”
BackgroundDevelopment of HVJ Envelope Vector and Its Application to Gene Therapy
Kaneda, Y., Yamamoto, S., & Nakajima, T. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)53012-8 · Cited by 55
In Vivo Effects of Insulin and Free Fatty Acids on Matrix Metalloproteinases in Rat Aorta
Boden, G. H., Song, W., Pashko, L. L., & Kresge, K. M. (2007) · Diabetes · doi:10.2337/db07-1261 · Cited by 57
“Third, several G protein–coupled receptors including GRP-40 and GRP-120 have been shown to bind FFA (47,48).”
BackgroundAdipose tissue deletion of Gpr116 impairs insulin sensitivity through modulation of adipose function
Nie, T., Hui, X. H., Gao, X., Li, K., Lin, W., Xiang, X., Ding, M., Kuang, Y., Xu, A., Fei, J., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.08.006 · Cited by 49
“GPR40, which is selectively expressed in pancreatic b cells, is required for free fatty acid evoked insulin secretion [8].”
BackgroundSánchez‐Alegría, K., & Arias, C. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.386 · Cited by 55
Hudson, B. D., Smith, N. J., & Milligan, G. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00006-3 · Cited by 53
The multiple roles of fatty acid handling proteins in brain
Moullé, V. S. F., Cansell, C., Luquet, S., & Cruciani-Guglielmacci, C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00385 · Cited by 49
“The binding of PUFAs to GPR40 initiates an intracellular cascade involving phospholipase C and phosphatidylinositol (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003).”
BackgroundAdipose differentiation-related protein regulates lipids and insulin in pancreatic islets
Faleck, D. M., Ali, K., Roat, R., Graham, M. J., Crooke, R. M., Battisti, R., Garcia, E., Ahima, R. S., & Imai, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00646.2009 · Cited by 49
“However, cellular uptake of fatty acids is also believed to contribute to the insulin secretion by provision of lipid metabolites, including long-chain acyl-CoA and diacylglycerides (25, 43, 65).”
Moran, B. M., Flatt, P. R., & McKillop, A. M. (2016) · Acta Diabetologica · doi:10.1007/s00592-015-0826-9 · Cited by 52
“GPR40 is activated by saturated fatty acids (capric acid, tricosanoic acid), monounsaturated (palmitoleic acid, oleic acid) and polyunsaturated fatty acids (linoleic acid, eicosatrienoic acid) with EC50 values in the micromolar range [36].”
BackgroundFridlyand, L. E., & Philipson, L. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152869 · Cited by 55
“Unbound FFAs in plasma in the physiological range can activate FFAR1/GPR40 in the presence of glucose and eventually amplifies GSIS in short-term exposure [106, 167].”
BackgroundQuercetin/Oleic Acid-Based G-Protein-Coupled Receptor 40 Ligands as New Insulin Secretion Modulators
Badolato, M., Carullo, G., Perri, M., Cione, E., Manetti, F., Gioia, M. L. D., Brizzi, A., Caroleo, M. C., & Aiello, F. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0113 · Cited by 52
Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ
Li, Z., Zhou, Z., Deng, F., Li, Y., Zhang, D., & Zhang, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.071 · Cited by 51
Marafie, S. K., ALSHAWAF, E. M. M., Abubaker, J. A., & Arefanian, H. (2019) · Biological Research · doi:10.1186/s40659-019-0253-4 · Cited by 53
de Souza, J., St-Pierre, N. R., & Lock, A. L. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16374 · Cited by 53
Wallin, T., Ma, Z., Ogata, H., Jørgensen, I. H., Iezzi, M., Wang, H., Wollheim, C. B., & Björklund, A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.002 · Cited by 49
Dhayal, S., Welters, H. J., & Morgan, N. G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.43 · Cited by 59
“Among these, GPR40 is highly expressed in pancreatic b-cells and has been implicated in the regulation of insulin secretion by fatty acids (Itoh et al., 2003; Shapiro et al., 2005; Briscoe et al., 2006).”
BackgroundCho, Y., Kim, S., Kim, P.-K., Jo, M. J., Park, S.-E., Choi, Y., Jung, S. M., & Kang, H. J. (2025) · Biomolecules · doi:10.3390/biom15020291 · Cited by 50
“…in Metabolic Physiology GPR40, or free fatty acid receptor 1 (FFAR1), is predominantly expressed in the brain, pancreatic β -cells, and intestinal enteroendocrine cells (L, K, and I cells) (Figure 2) [58,59]. in pancreatic β -cells and identified as an insulin secretion activator (Figure 1) [41].”
InfluentialEvidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice
MacPherson, R. E. K., Castellani, L. N., Beaudoin, M., & Wright, D. C. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00287.2014 · Cited by 52
Carpino, P. A., & Goodwin, B. J. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2010.533171 · Cited by 54
“Intriguingly, GPR40 was found to be highly expressed in pancreatic b-cells where it potentiated insulin secretion in response to fatty acids in a glucose-dependent manner [104,105].”
BackgroundRegulation of Energy Homeostasis via GPR120
Ichimura, A., Hara, T., & Hirasawa, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00111 · Cited by 53
Fatty Acid Binding Receptors and Their Physiological Role in Type 2 Diabetes
Swaminath, G. (2008) · Archiv der Pharmazie · doi:10.1002/ardp.200800096 · Cited by 54
A putative link of PUFA, GPR40 and adult-born hippocampal neurons for memory
Yamashima, T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.11.002 · Cited by 53
“Although it is possible that hippocampal adult-born neurons may contribute to other brain functions except for memory, such as emotions and stress regulation (Leuner et al., 2006), the most likely and what remains to be established are a definitive link between adult hippocampal neurogenesis and…”
BackgroundSpecific roles of saturated fatty acids: Beyond epidemiological data
Legrand, P., & Rioux, V. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400514 · Cited by 58
Kim, N., Lee, J. O., Lee, H. J., Kim, H. I., Kim, J. K., Lee, S. K., Lee, S. K., Kim, S. J., Park, S. H., & Kim, H. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657379 · Cited by 53
“Since the report on the involvement of GPR40 in free fatty acid-mediated insulin secretion (17), many studies have focused on GPCRs for developing antidiabetic drugs.”
BackgroundInfluentialDevelopment and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer
Christiansen, E., Hudson, B. D., Hansen, A. H., Milligan, G., & Ulven, T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00202 · Cited by 53
Zhang, K., Hu, Z., Qi, H.-X., Shi, Z., Chang, Y., Yao, Q., Cui, H., Zheng, L., Han, Y., Han, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11089 · Cited by 53
Neuman, J. C., Schaid, M. D., Brill, A. L., Fenske, R. J., Kibbe, C. R., Fontaine, D. A., Sdao, S. M., Brar, H. K., Connors, K. M., Wienkes, H. N., et al. (2017) · Diabetes · doi:10.2337/db16-1362 · Cited by 49
“Long-chain fatty acids, including EPA, can directly mediate signaling pathways potentially impacting b-cell function and health depending on whether they are transiently or chronically administered (2,39).”
BackgroundMARCINAK, J. F., Munsaka, M., Watkins, P. B., Ohira, T., & Smith, N. N. (2018) · Drug Safety · doi:10.1007/s40264-018-0642-6 · Cited by 49
“GPR40 is expressed on pancreatic islet cells [1].”
BackgroundMolecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
Lückmann, M., Trauelsen, M., Bentsen, M. A., Nissen, T. A. D., Martins, J. M. D. S., Fallah, Z., Nygaard, M. M., Papaleo, E., Lindorff‐Larsen, K., Schwartz, T. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811066116 · Cited by 47
Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance
Sugden, M. C., & Holness, M. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360891 · Cited by 47
Brownlie, R., Mayers, R. M., Pierce, J. A., Marley, A. E., & Smith, D. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360950 · Cited by 49
Sauer, L. A., Dauchy, R. T., Blask, D. E., Krause, J. A., Davidson, L. K., & Dauchy, E. M. (2005) · Journal of Nutrition · doi:10.1093/jn/135.9.2124 · Cited by 50
Fatty acids from diet and microbiota regulate energy metabolism
Alcock, J., & Lin, H. C. (2015) · F1000Research · doi:10.12688/f1000research.6078.1 · Cited by 52
The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism
Tomita, T., Hosoda, K., Fujikura, J., Inagaki, N., & Nakao, K. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00152 · Cited by 47
“ROLES OF GPR40 IN REGULATION OF INSULIN SECRETION In MIN6 cells, insulin secretion was augmented by LCFAs in a dose-dependent manner, and the augmentation was observed only under hyperglycemic conditions (11–22 mM) (5), indicating the LCFA-mediated augmentation of insulin secretion is glucosedependent.”
BackgroundMethodInfluentialOptimization of GPR40 Agonists for Type 2 Diabetes
Liu, J., Wang, Y., Ma, Z., Schmitt, M., Zhu, L., Brown, S. P., Dransfield, P. J., Sun, Y., Sharma, R. K., Guo, Q., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400501x · Cited by 47
Optical control of GPR40 signalling in pancreatic β-cells
Frank, J. A., Yushchenko, D. A., Fine, N. H. F., Duca, M., Citir, M., Broichhagen, J., Hodson, D. J., Schultz, C., & Trauner, D. H. (2017) · Chemical Science · doi:10.1039/c7sc01475a · Cited by 51
Obesity-induced asthma: Role of free fatty acid receptors
Mizuta, K., Matoba, A., Shibata, S., Masaki, E., & Emala, C. W. (2019) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2019.07.002 · Cited by 49
Biosensors design in yeast and applications in metabolic engineering
Qiu, C., Zhai, H., & Hou, J. (2019) · FEMS Yeast Research · doi:10.1093/femsyr/foz082 · Cited by 46
Wang, F., Ma, L., Ding, Y. G., He, L., Chang, M., Shan, Y., Siwko, S. K., Chen, G., Liu, Y., Jin, Y., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105406 · Cited by 46
The ins and outs of fatty acids on the pancreatic β cell
Poitout, V. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00086-9 · Cited by 58
Hong, J., Abudula, R., Chen, J., Jeppesen, P. B., Dyrskog, S., Xiao, J., Colombo, M., & Hermansen, K. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.022 · Cited by 57
Ohmoto, M., Okada, S., Nakamura, S., Abe, K., & Matsumoto, I. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22589 · Cited by 47
“Some mammalian GPCRs can receive fatty acids (Itoh et al., 2003; Hirasawa et al., 2005), and fish olfactory sensory neurons are activated by bile salts in the fish olfactory system (Døving et al., 1980; Li et al., 1993), although no GPCR belonging to class A or C and known to be involved in…”
BackgroundFlow Cytometry-Based Binding Assay for GPR40 (FFAR1; Free Fatty Acid Receptor 1)
Hara, T., Hirasawa, A., Sun, Q., Koshimizu, T., Itsubo, C., Sadakane, K., Awaji, T., & Tsujimoto, G. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052225 · Cited by 47
“They are activated by FFAs of different chain lengths with varying degrees of specificity, such that GPR40 (known as free fatty acid receptor 1; FFAR1), GPR84, and GPR120 prefer medium- to long-chain fatty acids (Itoh et al., 2003; Hirasawa et al., 2005; Wang et al., 2006), whereas GPR41 and GPR43, which are now calle…”
BackgroundInfluentialGateway to the metabolic syndrome
Medina‐Gómez, G., & Vidal‐Puig, A. (2005) · Nature Medicine · doi:10.1038/nm0605-602 · Cited by 48
Fukushima, K., Yamasaki, E., Ishii, S., Tomimatsu, A., Takahashi, K., Hirane, M., Fukushima, N., Honoki, K., & Tsujiuchi, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.050 · Cited by 47
“, Different roles o physical Research Communic pancreatic tissues, suggesting that GPR40 stimulates insulin secretion [8].”
BackgroundGPR40 gene expression in human pancreas and insulinoma
Tomita, T., Masuzaki, H., Noguchi, M., Iwakura, H., Fujikura, J., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.161 · Cited by 48
Medina-Gomez, G., Yetukuri, L., Velagapudi, V., Campbell, M., Blount, M., Jimenez-Linan, M., Ros, M., Orešič, M., & Vidal-Puig, A. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.003251 · Cited by 44
“Furthermore, expression of the gene encoding the Gprotein-coupled receptor GPR40, a membrane receptor activated by lipids and involved in lipotoxicity (Itoh et al., 2003; Itoh and Hinuma, 2005), was higher in islets from ob/ob mice compared with WT, PPAR2 KO and POKO mice (Fig.”
BackgroundUsui, R., Yabe, D., Fauzi, M. I., Goto, H., Botagarova, A., Tokumoto, S., Tatsuoka, H., Tahara, Y., Kobayashi, S., Manabe, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52048-1 · Cited by 49
O’Connell, T. D., Mason, R. P., Budoff, M. J., Návar, A. M., & Shearer, G. C. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa115 · Cited by 47
Lymperopoulos, A., Borges, J. I., Cora, N., & Sizova, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147684 · Cited by 47
“GPR40 is also known as FFA receptor type 1 (FFAR1), GPR43 as FFAR2, GPR41 as FFAR3, and GPR120 is also known as FFAR4 [34–37].”
BackgroundOgawa, T., Hirose, H., Miyashita, K., Saito, I., & Saruta, T. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.008 · Cited by 49
Godinot, N., Yasumatsu, K., Barcos, M. E., Pineau, N., Ledda, M., Viton, F., Ninomiya, Y., le Coutre, J., & Damak, S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.043 · Cited by 46
Macroautophagy: The key ingredient to a healthy diet?
Hannigan, A. M., & Gorski, S. M. (2009) · Autophagy · doi:10.4161/auto.5.2.7529 · Cited by 53
Bahar Halpern, K., Veprik, A., Rubins, N., Naaman, O., & Walker, M. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.358887 · Cited by 44
Briand, O., Helleboid‐Chapman, A., Ploton, M., Hennuyer, N., Carpentier, R., Pattou, F. N., Vandewalle, B., Moerman, E., Gmyr, V., Kerr-Conte, J. A., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1317 · Cited by 47
“Several mechanisms are involved in FFA-induced GSIS inhibition, including triglyceride storage, reactive oxygen species production through mitochondrial uncoupling, dysregulation of the glucose metabolic pathway (5), and GPR40 FFA membrane receptor activation (6).”
BackgroundTian, G., Sol, E.-R. M., Xu, Y., Shuai, H., & Tengholm, A. (2014) · Diabetes · doi:10.2337/db14-1036 · Cited by 47
“The mechanism behind the modest [cAMP]pm elevation triggered by acute palmitate treatment is not known but may be secondary to the elevation of [Ca]i by fatty acid–mediated activation of GPR40 receptors (31).”
BackgroundLipids - two sides of the same coin in lung fibrosis
Mamazhakypov, A., SCHERMULY, R. T., Schaefer, L., & Wygrecka, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.04.007 · Cited by 47
Gao, B., Huang, Q., Jie, Q., Zhang, H., Wang, L., Guo, Y., Sun, Z., Wei, B.-Y., Han, Y., Liu, J., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0367 · Cited by 47
“Long-chain FAs can activate GPR40 [47] and GPR120 [48].”
Karki, P., Kurihara, T., Nakamachi, T., Watanabe, J., Asada, T., Oyoshi, T., Shioda, S., Yoshimura, M., Arita, K., & Miyata, A. (2015) · Molecular Pain · doi:10.1186/s12990-015-0003-8 · Cited by 44
“As mentioned above, GPR40 binds a broad range of structurally and chemically distinct ligands, and several reports suggests that GPR40 can couple to Gαi [2,49] and Gαs [50] as well as Gq/11, with which GPR40 is known to mainly couple in pancreatic β-cells to regulate insulin secretion [4].”
BackgroundG Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ)
Wang, S., Awad, K. S., Elinoff, J. M., Dougherty, E. J., Ferreyra, G. A., Wang, J. Y., Cai, R., Sun, J., Ptasinska, A., & Danner, R. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638924 · Cited by 49
“Notably, GPR40, also known as free fatty acid receptor 1, has been implicated in fatty acid- and glucose-induced insulin secretion (35, 36), effects also regulated by PPAR (37, 38).”
BackgroundGastrointestinal targets to modulate satiety and food intake
Geraedts, M. C. P., Troost, F. J., & Saris, W. H. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00788.x · Cited by 49
“A wide range of medium- and long-chain FFAs have been identified as agonists of the FFA1 receptor, with eicosatriynoic acid (C20:3) being the most potent example (61,63,68).”
BackgroundSun, P. G., Wang, T., Zhou, Y., Liu, H., Jiang, H., Zhu, W., & Wang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066744 · Cited by 47
“Growing evidence indicated that some free fatty acids, such as palmitate could mobilize the Ca release and amplify GSIS in bcells via GPR40, but the chronic palmitate treatment could induce an increased risk of b-cell dysfunction [6,32,33].”
BackgroundInfluentialHuang, Q., Feng, D., Liu, K., Wang, P., Xiao, H., Wang, Y., Zhang, S., & Liu, Z. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.03.017 · Cited by 45
Helker, C. S., Mullapudi, S. T., Mueller, L. M., Preussner, J., Tunaru, S., Skog, O., Kwon, H.-B., Kreuder, F., Lancman, J. J., Bonnavion, R., et al. (2019) · Development · doi:10.1242/dev.172569 · Cited by 45
“GPR40 is abundantly expressed by β-cells and it has been shown that the activation of GPR40 by agonists amplifies GSIS (Itoh et al., 2003).”
BackgroundInfluentialModulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists
Chen, L., Zhang, Q., Xie, X., & Nan, F. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01378 · Cited by 42
Fat fuels insulin resistance through Toll-like receptors
Tschöp, M. H., & Thomas, G. (2006) · Nature Medicine · doi:10.1038/nm1206-1359 · Cited by 48
Wu, H., Chen, W., Cheng, K., Ku, P., Yeh, C., & Cheng, J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.07.006 · Cited by 49
The Free Fatty Acid Receptor GPR40 Generates Excitement in Pancreatic β-Cells
Gromada, J. (2006) · Endocrinology · doi:10.1210/en.2005-1388 · Cited by 48
Zhang, X., Yan, G., Li, Y., Zhu, W., & Wang, H. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.06.008 · Cited by 44
A Tutorial on Fatty Acid Biology
Kalish, B. T., Fallon, E. M., & Puder, M. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112449650 · Cited by 42
Gras, D., Chanez, P., Urbach, V., Vachier, I., Godard, P., & Bonnans, C. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90219.2008 · Cited by 48
“Among them, the GPR40 receptor is described to be specifically activated by free fatty acids and TZDs (9, 20, 24).”
Nguyen, T. H., & Kim, S. M. (2015) · Journal of Food Science · doi:10.1111/1750-3841.12810 · Cited by 45
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.